Surface cathepsin B protects cytotoxic lymphocytes from self-destruction after degranulation

Balaji KN, Schaschke N, Machleidt W, Catalfamo M, Henkart PA (2002)
JOURNAL OF EXPERIMENTAL MEDICINE 196(4): 493-503.

Journal Article | Published | English

No fulltext has been uploaded

Author
; ; ; ;
Publishing Year
ISSN
eISSN
PUB-ID

Cite this

Balaji KN, Schaschke N, Machleidt W, Catalfamo M, Henkart PA. Surface cathepsin B protects cytotoxic lymphocytes from self-destruction after degranulation. JOURNAL OF EXPERIMENTAL MEDICINE. 2002;196(4):493-503.
Balaji, K. N., Schaschke, N., Machleidt, W., Catalfamo, M., & Henkart, P. A. (2002). Surface cathepsin B protects cytotoxic lymphocytes from self-destruction after degranulation. JOURNAL OF EXPERIMENTAL MEDICINE, 196(4), 493-503.
Balaji, K. N., Schaschke, N., Machleidt, W., Catalfamo, M., and Henkart, P. A. (2002). Surface cathepsin B protects cytotoxic lymphocytes from self-destruction after degranulation. JOURNAL OF EXPERIMENTAL MEDICINE 196, 493-503.
Balaji, K.N., et al., 2002. Surface cathepsin B protects cytotoxic lymphocytes from self-destruction after degranulation. JOURNAL OF EXPERIMENTAL MEDICINE, 196(4), p 493-503.
K.N. Balaji, et al., “Surface cathepsin B protects cytotoxic lymphocytes from self-destruction after degranulation”, JOURNAL OF EXPERIMENTAL MEDICINE, vol. 196, 2002, pp. 493-503.
Balaji, K.N., Schaschke, N., Machleidt, W., Catalfamo, M., Henkart, P.A.: Surface cathepsin B protects cytotoxic lymphocytes from self-destruction after degranulation. JOURNAL OF EXPERIMENTAL MEDICINE. 196, 493-503 (2002).
Balaji, KN, Schaschke, Norbert, Machleidt, W, Catalfamo, M, and Henkart, PA. “Surface cathepsin B protects cytotoxic lymphocytes from self-destruction after degranulation”. JOURNAL OF EXPERIMENTAL MEDICINE 196.4 (2002): 493-503.
This data publication is cited in the following publications:
This publication cites the following data publications:

77 Citations in Europe PMC

Data provided by Europe PubMed Central.

Melanoma cell lysosome secretory burst neutralizes the CTL-mediated cytotoxicity at the lytic synapse.
Khazen R, Muller S, Gaudenzio N, Espinosa E, Puissegur MP, Valitutti S., Nat Commun 7(), 2016
PMID: 26940455
Ectopically expressed perforin-1 is proapoptotic in tumor cell lines by increasing caspase-3 activity and the nuclear translocation of cytochrome C.
Wang LF, Wang F, Li JT, Wen WH, Zhao J, Jia LT, Meng YL, Cao YX, Yao LB, Chen SY, Xu YM, Yang AG., PLoS ONE 7(7), 2012
PMID: 22829880

59 References

Data provided by Europe PubMed Central.

The granzyme B inhibitor, protease inhibitor 9, is mainly expressed by dendritic cells and at immune-privileged sites.
Bladergroen BA, Strik MC, Bovenschen N, van Berkum O, Scheffer GL, Meijer CJ, Hack CE, Kummer JA., J. Immunol. 166(5), 2001
PMID: 11207275
Natural killer and lymphokine-activated killer cells require granzyme B for the rapid induction of apoptosis in susceptible target cells.
Shresta S, MacIvor DM, Heusel JW, Russell JH, Ley TJ., Proc. Natl. Acad. Sci. U.S.A. 92(12), 1995
PMID: 7777569
Viral immune evasion strategies and the underlying cell biology.
Lorenzo ME, Ploegh HL, Tirabassi RS., Semin. Immunol. 13(1), 2001
PMID: 11289794
Cell surface complex of cathepsin B/annexin II tetramer in malignant progression.
Mai J, Waisman DM, Sloane BF., Biochim. Biophys. Acta 1477(1-2), 2000
PMID: 10708859
A fresh look at tumor immunosurveillance and immunotherapy.
Smyth MJ, Godfrey DI, Trapani JA., Nat. Immunol. 2(4), 2001
PMID: 11276199
A role for perforin in activation-induced cell death.
Spaner D, Raju K, Radvanyi L, Lin Y, Miller RG., J. Immunol. 160(6), 1998
PMID: 9510164
A role for perforin in downregulating T-cell responses during chronic viral infection.
Matloubian M, Suresh M, Glass A, Galvan M, Chow K, Whitmire JK, Walsh CM, Clark WR, Ahmed R., J. Virol. 73(3), 1999
PMID: 9971838

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 12186841
PubMed | Europe PMC

Search this title in

Google Scholar